The Eurasian Journal of Medicine
Original Article

High-Frequency Chest Wall Oscillation in Patients with COVID-19: A Pilot Feasibility Study

1.

Department of Anesthesiology and Reanimation, Atatürk University Faculty of Medicine, Erzurum, Turkey

2.

Clinical Research, Development and Design Application and Research Center, Atatürk University Faculty of Medicine, Erzurum, Turkey

3.

Department of Pulmonary Diseases, Atatürk University Faculty of Medicine, Erzurum, Turkey

4.

Department of Infection Diseases and Clinical Microbiology, Erzurum Regional Education and Research Hospital, University of Health Sciences, Erzurum, Turkey

5.

Department of Anesthesiology and Reanimation, Erzurum Regional Education and Research Hospital, University of Health Sciences, Erzurum, Turkey

6.

Department of Pulmonary Diseases, Erzurum Regional Education and Research Hospital, University of Health Sciences, Erzurum, Turkey

7.

Department of Pathology, Atatürk University Faculty of Medicine, Erzurum, Turkey

8.

Department of Medical Microbiology, Erzurum Regional Education and Research Hospital, Erzurum, University of Health Sciences, Turkey

9.

Department of Mechanical Engineering, Atatürk University Faculty of Engineering, Erzurum, Turkey

Eurasian J Med 2022; 54: 150-156
DOI: 10.5152/eurasianjmed.2022.21048
Read: 344 Downloads: 160 Published: 01 June 2022

Objective: Coronavirus 2019 disease presents in a spectrum that can range from mild viral infection to pneu- monia. Common symptoms of coronavirus disease 2019 pneumonia include cough, sputum, and shortness of breath. High-frequency chest wall oscillation is a pulmonary rehabilitation method used for the recovery of pulmonary functions and removal of secretions in the lungs. The aim of the study was to evaluate the efficacy of high-frequency chest wall oscillation on patients with coronavirus disease 2019 pneumonia.

Materials and Methods: In this study, 100 patients, between 18 and 70 years old, with a positive polymerase chain reaction result for coronavirus disease 2019, were included. Standard medical treatment was applied to all patients. In group rehabilitation, high-frequency chest wall oscillation treatment was applied twice a day for 20 minutes for 5 days. No additional intervention was made to the control group. Pulmonary function tests and oxygenation were evaluated on the first and fifth days. Patients’ high-flow oxygen, non-invasive mechani- cal ventilation, and invasive mechanical ventilation needs were evaluated and recorded.

Results: Compared with the control group, the forced expiratory volume in 1 second, forced vital capacity, and peak expiratory flow rates were statistically higher in the rehabilitation group on the fifth day (P < .05). On evaluating the oxygenation of patients, the fifth day to first-day oxygen saturation difference was signifi- cantly higher in rehabilitation group than in control group (P < .05). Furthermore, the number of patients who needed non-invasive mechanical ventilation was lower in the rehabilitation group (P < .05).

Conclusion: This study demonstrated that pulmonary rehabilitation applied with the high-frequency chest wall oscillation device in patients with coronavirus disease 2019 in the early period contributed to the improvement of oxygenation by providing significant improvement as observed in the pulmonary function tests of the patients.

Cite this article as: Çelik M, Murat Yayık A, Kerget B, et al. High-frequency chest wall oscillation in patients with COVID-19: A pilot feasibility study. Eurasian J Med 2022;54(2):150-156.

Files
EISSN 1308-8742